Dss's impact biomedical receives notice of allowance for 3f biofragrance patent

Rochester, n.y., jan. 14, 2021 (globe newswire) -- document security systems, inc. (“dss” or the “company”) (nyse american: dss), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced its wholly owned subsidiary impact biomedical, inc. (“impact biomedical”) received notice of allowance from the u.s. patent and trademark office (“uspto”) for a [method/composition] patent for its proprietary 3f biofragrance.
DSS Ratings Summary
DSS Quant Ranking